Related references
Note: Only part of the references are listed.High D-dimer levels are associated with poor prognosis in cancer patients
Cihan Ay et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Biased estimation of thrombosis rates in cancer studies using the method of Kaplan and Meier
F. Campigotto et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Accounting for death as a competing risk in cancer-associated thrombosis studies
Federico Campigotto et al.
THROMBOSIS RESEARCH (2012)
Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism
S. Parpia et al.
CONTEMPORARY CLINICAL TRIALS (2011)
Prediction of venous thromboembolism in cancer patients
Cihan Ay et al.
BLOOD (2010)
D-Dimer and Prothrombin Fragment 1+2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study
Cihan Ay et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cumulative incidence in competing risks data and competing risks regression analysis
Haesook T. Kim
CLINICAL CANCER RESEARCH (2007)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
